Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.

NCT07051928 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

107

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DIAGNOSTIC_TEST: c-FLIP expression on MDSC

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS